The Global Atherectomy Devices Market size is expected to reach $900.7 million by 2025, rising at a market growth of 6.8% CAGR during the forecast period (2019-2025) - GlobeNewswire
Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Comments
Post a Comment